Adolescent MenACWY Booster Study

PHASE4CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

August 1, 2021

Study Completion Date

August 1, 2021

Conditions
Meningococcal Disease, Invasive
Interventions
BIOLOGICAL

MenACWY-CRM

Booster vaccination with MenACWY-CRM

BIOLOGICAL

MenACWY-DT

Booster vaccination with MenACWY-DT

BIOLOGICAL

MenACWY-TT

Booster vaccination with MenACWY-TT

Trial Locations (3)

Unknown

Children's Hospital Research Institute, University of Calgary, Calgary

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver

Canadian Center for Vaccinology, Halifax

All Listed Sponsors
collaborator

University of British Columbia

OTHER

collaborator

University of Calgary

OTHER

collaborator

Canadian Center for Vaccinology

OTHER

collaborator

Alberta Health services

OTHER

collaborator

British Columbia Centre for Disease Control

OTHER_GOV

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Dalhousie University

OTHER

lead

Canadian Immunization Research Network

NETWORK

NCT03694405 - Adolescent MenACWY Booster Study | Biotech Hunter | Biotech Hunter